TRACON Pharmaceutical (TCON) Tops Q2 EPS by 13c

TRACON Pharmaceutical (NASDAQ: TCON) reported Q2 EPS of ($0.20), $0.13 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $9 million.

For earnings history and earnings-related data on TRACON Pharmaceutical (TCON) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• Femasys Inc. (FEMY) Misses Q2 EPS by 20c
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30